sitagliptin-phosphate has been researched along with Leukopenia* in 1 studies
1 other study(ies) available for sitagliptin-phosphate and Leukopenia
Article | Year |
---|---|
Severe leucopenia associated with Sitagliptin use.
We report the case of a type 2 diabetes subject who developed severe leucopenia associated with treatment with the dipeptidil-peptidase 4 enzyme inhibitor Sitagliptin and highlights DPP4 inhibitors as a possible cause of unexplained hematolgical abnormalities in patients receiving DPP4-inhibitor treatment. Topics: Aged; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Leukopenia; Male; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |